Eye Health America

Belkins
Eye Health America partners with eye care practices and ambulatory surgery centers to provide superior clinical care. Our member practices offer full-service eye care from routine eye exams, contact lenses and glasses to medical ophthalmology and surgery including cataract, cornea, retina, glaucoma, pediatrics and oculoplastics. We support practice groups and ASCs as they grow locations and service offerings, enabling them to focus on delivering the highest quality outcomes and meeting a rapidly growing need for eye care. Visit www.eyehealthamerica.com to learn more.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMACY MARKET

AIZON LAUNCHES GXP AI BIOREACTOR APPLICATION FOR THE PHARMA INDUSTRY

Aizon | February 02, 2021

news image

Aizon launches its Bioreactor Application, the pharma industry's first predictive analysis and profound knowledge management application. The Aizon Bioreactor Application adds the bioreactor process to the "Smart Manufacturing" transformation that is accelerating across the Pharma and Biotech industry. Aizon is extraordinarily able to achieve GxP compliance and give an audit trail from the start of the process. The turnkey application allows pharmaceutical and biotech companies to ...

Read More

CLARIFY HEALTH LAUNCHES NEXT-GENERATION ANALYTICS TO ASSIST PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

Clarify Health | July 01, 2020

news image

Clarify Health, a leading healthcare analytics company, announced that its life sciences software, Clarify Launch, now includes innovative enhancements that give brand teams a faster and more effective way to identify market opportunities to drive growth. The ability to explore over 300 million longitudinal patient care journeys using Clarify Launch offers brand teams rapid access to actionable insights within specific patient populations. Clarify brings first-of-their-kind patient segmentation,...

Read More

RESEARCH

ROIVANT GROWS COMPUTATIONAL DRUG DISCOVERY ENGINE WITH ACQUISITION OF SILICON THERAPEUTICS

Roivant Sciences | March 01, 2021

news image

Silicon Therapeutics has assembled an exclusive industry-driving computational physics platform for the in silico design and optimization of small molecule drugs for testing disease targets. The platform incorporates custom strategies dependent on quantum mechanics, sub-atomic elements and measurable thermodynamics to beat basic bottlenecks in drug disclosure projects, for example, anticipating restricting energies and conformational conduct of molecules. Silicon Therapeutics'...

Read More

RESEARCH

GILEAD GETS WHO COLD SHOULDER FOR REMDESIVIR IN COVID-19, LAUNCHES SPEEDY DEFENSE

Gilead | November 21, 2020

news image

Gilead Sciences’ Veklury, better known as remdesivir, is so far the only COVID-19 therapy officially approved by the FDA, but the World Health Organization has some other ideas about the drug’s worth. At clear odds with the FDA’s approval, the WHO has for now recommended against the use of remdesivir in any hospitalized patients—regardless of disease severity—after an expert panel said it had found no evidence that remdesivir has any meaningful effect...

Read More

PHARMACY MARKET

Aizon | February 02, 2021

news image

AIZON LAUNCHES GXP AI BIOREACTOR APPLICATION FOR THE PHARMA INDUSTRY

Aizon launches its Bioreactor Application, the pharma industry's first predictive analysis and profound knowledge management application. The Aizon Bioreactor Application adds the bioreactor process to the "Smart Manufacturing" transformation that is accelerating across the Pharma and Biotech industry. Aizon is extraordinarily able to achieve GxP compliance and give an audit trail from the start of the process. The turnkey application allows pharmaceutical and biotech companies to ...

Read More

Clarify Health | July 01, 2020

news image

CLARIFY HEALTH LAUNCHES NEXT-GENERATION ANALYTICS TO ASSIST PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

Clarify Health, a leading healthcare analytics company, announced that its life sciences software, Clarify Launch, now includes innovative enhancements that give brand teams a faster and more effective way to identify market opportunities to drive growth. The ability to explore over 300 million longitudinal patient care journeys using Clarify Launch offers brand teams rapid access to actionable insights within specific patient populations. Clarify brings first-of-their-kind patient segmentation,...

Read More

RESEARCH

Roivant Sciences | March 01, 2021

news image

ROIVANT GROWS COMPUTATIONAL DRUG DISCOVERY ENGINE WITH ACQUISITION OF SILICON THERAPEUTICS

Silicon Therapeutics has assembled an exclusive industry-driving computational physics platform for the in silico design and optimization of small molecule drugs for testing disease targets. The platform incorporates custom strategies dependent on quantum mechanics, sub-atomic elements and measurable thermodynamics to beat basic bottlenecks in drug disclosure projects, for example, anticipating restricting energies and conformational conduct of molecules. Silicon Therapeutics'...

Read More

RESEARCH

Gilead | November 21, 2020

news image

GILEAD GETS WHO COLD SHOULDER FOR REMDESIVIR IN COVID-19, LAUNCHES SPEEDY DEFENSE

Gilead Sciences’ Veklury, better known as remdesivir, is so far the only COVID-19 therapy officially approved by the FDA, but the World Health Organization has some other ideas about the drug’s worth. At clear odds with the FDA’s approval, the WHO has for now recommended against the use of remdesivir in any hospitalized patients—regardless of disease severity—after an expert panel said it had found no evidence that remdesivir has any meaningful effect...

Read More